Morning @@bernsta Yes ,, my primary interest is the Anti-Skin...

Thanks @dashmarr ,, its Market Messaging like this that needs to be assembled on the Syntara website,,, a few investors here are over at NUZ and NUZ have utilised an Investor Centre Section on their website.

Investors /SH can ask questions directly to Management and it takes the repetition out of answering multiple questions/emails that are the same ,, plus its transparent so everyone can see the CEO answering questions from the top,,, this negates any uncertainty and avoids unnecessary speculation .
Michael Thurn the CEO has been really diligent with only a small time delay for when he answers...
The site also compiles links to video's and previous presentations..

This would seem like a worthwhile model for SNT ,,, ?? as I have found Gary poor at responding to any questions sent by at least 4 investors from here??

NUZ had been suffering from poor communication and market messaging but now it is taking on board new investors and that has added to liquidity also.

Morning @@bernsta Yes ,, my primary interest is the Anti-Skin Scarring Treatment , there is no current SOC (Standard of Care) take home pack even for surgical scars ... a family member recently had throat surgery 'she was quite conscious of the possibility of scarring" the Hospital had supplied her with a tape to keep tension on the scar after the stitches dissolved, that was on for 3 months to reduce the scar possibility,, not ideal and the outcome was subpar.
Now the trial had been on established scars I believe with one patient it was a 7 year old scar... and some of the scars where significant... a laceration , impact scar or burn leave rough uneven edges ,,, so imagine a precise surgical scar carried out with a scalpel to then be treated with SNT 9465?
and I would expect every single patient to have a take home pack or at least be able to be prescribed a small tube of SNT 9465,,, this is virtually a first in class medicine with no incumbents or established players to compete with..

Plus Prof Wood has already built a commercialisation network for Spray on Skin,,, that company is ASX Listed and only has a single treatment offering
Avita who have an MC of $280m and an SP of $2.12,,, so I have a pretty good idea who will be our target Buyer or Partner for SNT 9465...NZT

https://www.listcorp.com/asx/snt/syntara-limited/news/snt-drug-leads-to-significant-normalisation-of-skin-scarring-3152626.html